Rna Diagnostics Inc - Product Pipeline Analysis, 2020 Update

Summary

Rna Diagnostics Inc (Rna Diagnostics) is a medical device company that discovers and develops medical diagnostics molecular diagnostic technologies. The company offers diagnostic tools used in treatment of women undergoing chemotherapy for breast cancer. It also provides solutions to manage cancer and other disease states. Rna Diagnostics’ RNA disruption assay allows oncologists to examine the biological structure of a patient’s tumor during treatment to determine its response to chemotherapy. The company collaborates with research clinicians, university researchers, and hospitals located in Canada, the US and other countries. It operates through its laboratories located across Ontario, Canada. Rna Diagnostics is headquartered in Toronto, Ontario, Canada.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Rna Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Rna Diagnostics Inc Company Overview
Rna Diagnostics Inc Company Snapshot
Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Rna Diagnostics Inc – Pipeline Analysis Overview
Rna Diagnostics Inc - Key Facts
Rna Diagnostics Inc - Major Products and Services
Rna Diagnostics Inc Pipeline Products by Development Stage
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status
Rna Diagnostics Inc Pipeline Products Overview
RNA Disruption Assay - Breast Cancer
RNA Disruption Assay - Breast Cancer Product Overview
RNA Disruption Assay - Breast Cancer Clinical Trial
RNA Disruption Assay - Head & Neck Cancer
RNA Disruption Assay - Head & Neck Cancer Product Overview
RNA Disruption Assay - Ovarian Cancer
RNA Disruption Assay - Ovarian Cancer Product Overview
RNA Disruption Assay - Rectal Cancer
RNA Disruption Assay - Rectal Cancer Product Overview
RNA Disruption Assay - Sarcoma
RNA Disruption Assay - Sarcoma Product Overview
Rna Diagnostics Inc - Key Competitors
Rna Diagnostics Inc - Key Employees
Rna Diagnostics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Rna Diagnostics Inc, Recent Developments
May 17, 2018: Rna Diagnostics Aims for 2020 Clinical Launch of Breast Cancer Treatment Guidance Test
Apr 27, 2018: First patient enrolled in BREVITY, Rna Diagnostics’ International Validation Trial of RDA in Primary Breast Cancer
Jul 06, 2017: Rna Diagnostics Appoints Dr. Matthew P. Goetz to Clinical Advisory Board
Jun 14, 2017: Rna Diagnostics Launches BREVITY – International Validation Trial of RDA in Breast Cancer
Sep 15, 2016: Further Evidence RDA May Predict Clinical Outcome Of Chemotherapy In Journal Of The National Cancer Institute
Apr 01, 2016: Rna Diagnostics appoints Dr. Jeremy Bridge-Cook President and CEO
Feb 18, 2016: Paul Lucas joins the Board of Directors at Rna Diagnostics
May 30, 2013: Rna Diagnostics Selected To Participate In Excite Program To Evaluate RNA Disruption Assay
Feb 19, 2013: Rna Diagnostics Gets $462,500 Grant From FedDev Ontario For RNA Disruption Assay
Nov 02, 2012: Denis Ho joins Rna Diagnostics’ Board of Directors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Rna Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
Rna Diagnostics Inc Pipeline Products by Equipment Type
Rna Diagnostics Inc Pipeline Products by Indication
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status
Rna Diagnostics Inc, Key Facts
Rna Diagnostics Inc, Major Products and Services
Rna Diagnostics Inc Number of Pipeline Products by Development Stage
Rna Diagnostics Inc Pipeline Products Summary by Development Stage
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status
Rna Diagnostics Inc Ongoing Clinical Trials Summary
RNA Disruption Assay - Breast Cancer - Product Status
RNA Disruption Assay - Breast Cancer - Product Description
RNA Disruption Assay - Breast Cancer - Breast Cancer Response Evaluation for Individualized Therapy: BREVITY
RNA Disruption Assay - Head & Neck Cancer - Product Status
RNA Disruption Assay - Head & Neck Cancer - Product Description
RNA Disruption Assay - Ovarian Cancer - Product Status
RNA Disruption Assay - Ovarian Cancer - Product Description
RNA Disruption Assay - Rectal Cancer - Product Status
RNA Disruption Assay - Rectal Cancer - Product Description
RNA Disruption Assay - Sarcoma - Product Status
RNA Disruption Assay - Sarcoma - Product Description
Rna Diagnostics Inc, Key Employees
Rna Diagnostics Inc, Other Locations
Glossary
List of Figures
Rna Diagnostics Inc Pipeline Products by Equipment Type
Rna Diagnostics Inc Pipeline Products by Development Stage
Rna Diagnostics Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings